Chao YK - Search Results

1

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.

Yap WK, Shih MC, Chang YC, Lin CH, Huang SM, Tsai TY, Chang CF, Hsu CC, Tseng CK, Chen MF, Tsan DL, Liau CT, Hou MM, Chao YK, Chiu CH, Hung TM. Yap WK, et al. Among authors: chao yk. Biomedicines. 2022 Nov 21;10(11):2989. doi: 10.3390/biomedicines10112989. Biomedicines. 2022. PMID: 36428557 Free PMC article.

2

Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma.

Chuang WY, Yeh CJ, Wu YC, Chao YK, Liu YH, Tseng CK, Chang HK, Liu HP, Hsueh C. Chuang WY, et al. Among authors: chao yk. Histol Histopathol. 2009 Aug;24(8):1021-7. doi: 10.14670/HH-24.1021. Histol Histopathol. 2009. PMID: 19554509

3

Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.

Chao YK, Wu YC, Liu YH, Tseng CK, Chang HK, Hsieh MJ, Chu Y, Liu HP. Chao YK, et al. J Surg Oncol. 2010 Aug 1;102(2):158-62. doi: 10.1002/jso.21588. J Surg Oncol. 2010. PMID: 20648587

4

Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.

Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP. Chao YK, et al. Ann Surg Oncol. 2011 Feb;18(2):529-34. doi: 10.1245/s10434-010-1244-4. Epub 2010 Aug 10. Ann Surg Oncol. 2011. PMID: 20697822

5

High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.

Yeh CJ, Chuang WY, Chao YK, Liu YH, Chang YS, Kuo SY, Tseng CK, Chang HK, Hsueh C. Yeh CJ, et al. Among authors: chao yk. Virchows Arch. 2011 Feb;458(2):171-8. doi: 10.1007/s00428-010-0994-5. Epub 2010 Nov 3. Virchows Arch. 2011. PMID: 21046149

6

Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients.

Chao YK, Chuang WY, Yeh CJ, Wu YC, Liu YH, Hsieh MJ, Cheng AJ, Hsueh C, Liu HP. Chao YK, et al. J Surg Oncol. 2012 Feb;105(2):183-8. doi: 10.1002/jso.22068. Epub 2011 Aug 30. J Surg Oncol. 2012. PMID: 22213642

7

Impact of the number of lymph nodes sampled on outcome in ypT0N0 esophageal squamous cell carcinoma patients.

Chao YK, Liu HP, Hsieh MJ, Wu YC, Liu YH, Yeh CH, Chang HK, Tseng CK. Chao YK, et al. J Surg Oncol. 2012 Sep 15;106(4):436-40. doi: 10.1002/jso.23103. Epub 2012 May 4. J Surg Oncol. 2012. PMID: 22566367

8

Lymph node dissection after chemoradiation in esophageal cancer: a subgroup analysis of patients with and without pathological response.

Chao YK, Liu HP, Hsieh MJ, Wu YC, Liu YH, Yeh CH, Chang HK, Tseng CK. Chao YK, et al. Ann Surg Oncol. 2012 Oct;19(11):3500-5. doi: 10.1245/s10434-012-2402-7. Epub 2012 May 24. Ann Surg Oncol. 2012. PMID: 22622470

9

Using pretreatment tumor depth and length to select esophageal squamous cell carcinoma patients for nonoperative treatment after neoadjuvant chemoradiotherapy.

Chao YK, Tseng CK, Wen YW, Liu YH, Wan YL, Chiu CT, Chang WC, Chang HK. Chao YK, et al. Ann Surg Oncol. 2013 Sep;20(9):3000-8. doi: 10.1245/s10434-013-2962-1. Epub 2013 Apr 13. Ann Surg Oncol. 2013. PMID: 23584515

10

Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?

Chiu CH, Chao YK, Chang HK, Tseng CK, Chan SC, Liu YH, Chen WH. Chiu CH, et al. Among authors: chao yk. Ann Surg Oncol. 2013 Dec;20(13):4245-51. doi: 10.1245/s10434-013-3139-7. Ann Surg Oncol. 2013. PMID: 23959050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page